Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
about
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesisThe cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancerEpidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cellsApoptosis: targets in pancreatic cancerPathways for aberrant angiogenesis in pancreatic cancerEffects of STI571 (gleevec) on pancreatic cancer cell growthImmunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent CancersThe TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerInfluences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinomaOverexpression of activin A in stage IV colorectal cancerEnhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitisBioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkersIdentification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activityIncreased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Expression of vascular endothelial growth factors A and C in human pancreatic cancer.Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.Biological approaches to therapy of pancreatic cancer.Pancreatic cancer: molecular pathogenesis and new therapeutic targets.Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells.Adult pancreatic acinar cells give rise to ducts but not endocrine cells in response to growth factor signaling.Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth.DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistanceChemoprevention strategies for pancreatic cancerEndonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas.Growth factors and their receptors in pancreatic cancer.EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.Gene therapy in pancreatic cancer.Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma.A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancerLigand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.Biology and management of pancreatic cancer.The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growthOncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.Developments in the systemic therapy of pancreatic cancer.Systemic therapy for advanced pancreatic cancer.
P2860
Q21245763-DC59742A-3DEB-456C-9A56-6BA29064AA3EQ24564355-AF2D06F4-BE3F-4616-A9EC-1392A1EAC3BAQ24792963-A40EC999-30B6-4C5F-B0BA-72C225D4739FQ24800170-E8287156-24CA-47F9-8F09-138E97BE776CQ24800215-7978E71F-CE78-4FB1-8399-7FDC68398D09Q24802841-F67D826D-1806-4258-943F-3B04FACDFBD0Q26751473-6DCE9B50-EBAC-4C2A-95D5-529D04B96116Q28145081-DF0F6540-951E-48D8-AA65-8C66A9884F57Q28216866-D8ACDC6A-7A43-4CBD-B002-A77FD345D1BDQ28346273-3B867B8C-124E-40F8-97B4-273E3664BD13Q28369085-F5CCF7F6-C1ED-4274-B2E9-7F22EFE09531Q28834154-B5D0C366-31CA-447A-9FDA-75F8EF103F55Q33520350-7651F892-44AF-441E-B6C4-2D458ECC2CA7Q33617690-A7CA36A7-FF62-4157-9E67-57CD380C2B93Q33684453-3FA8EE12-9E6C-4381-AE21-D689D4F041ACQ33788147-C1B51295-390E-45B4-A1B2-C80BBE89A922Q33888876-BFC25FB8-70FE-4D19-9831-CFFD49AE98C4Q33899938-36873801-9FD1-4EDC-B0F7-E3A9F38A5CEAQ33899954-3F3D4375-2CA9-4F00-BA77-A1216D80A529Q33902109-C4AC3BBF-60C2-44B8-90A3-0641B927E414Q33929630-B7CF09CD-6B32-4F0B-B609-18EE261EFB1EQ34066456-8CD6E879-C1C9-41C4-B356-34CD3319876DQ34067050-29DA5F07-B27F-427F-977C-BA93DF64EEF6Q34082960-CF06E4CF-3B72-422D-9722-498DCC47688DQ34114668-81263FFE-98A5-423C-80C7-CA66C88871E1Q34116893-DD83D719-CF90-487E-8BEF-4400AFD7D67CQ34163334-20C50BD8-4195-4E25-B6B3-C5F518A8C665Q34302954-9D221366-D453-4295-8373-D0BF0C2D3F6FQ34326442-25CB0399-3486-4556-841E-90B71043820AQ34375528-F604DEED-F032-43E2-8EE2-2733955B2569Q34379846-1D944FD0-3AEA-47C5-AE03-77E22A2D7BE8Q34398312-8D15A5AF-F4B5-41E3-A3E9-3BD171AFDF03Q34496697-C57CCA80-9932-44A9-8123-FD6A17498AB1Q34642090-0C6D6CBF-D0E9-44F6-9F7D-E443B92CE48AQ34649019-BE340D49-007D-4176-B9BC-589359795956Q34681112-E6AB9379-43C5-43D1-8F36-88CA5F30B0F3Q34812100-77BA435B-4EA5-4D85-8105-A9FBD6A4FC55Q35067751-84B2D70E-531D-41F5-848F-6D9C7B877C5FQ35087326-D59CA3D9-11E9-4D25-A017-52D93D7A4C2FQ35089138-82F683D5-3A3C-4504-9078-625B73727520
P2860
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Overexpression of the epiderma ...... ansforming growth factor alpha
@ast
Overexpression of the epiderma ...... ansforming growth factor alpha
@en
type
label
Overexpression of the epiderma ...... ansforming growth factor alpha
@ast
Overexpression of the epiderma ...... ansforming growth factor alpha
@en
prefLabel
Overexpression of the epiderma ...... ansforming growth factor alpha
@ast
Overexpression of the epiderma ...... ansforming growth factor alpha
@en
P2093
P2860
P356
P1476
Overexpression of the epiderma ...... ansforming growth factor alpha
@en
P2093
P2860
P304
P356
10.1172/JCI116001
P407
P577
1992-10-01T00:00:00Z